© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 10, 803-811,
May 17, 2000
© 2000 Oxford University Press
Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
Affiliations of authors: L. E. Smith, M. F. Denissenko, G. P. Pfeifer (Department of Biology), W. P. Bennett (Department of Human Genetics), Beckman Research Institute of the City of Hope, Duarte, CA; H. Li, M.-s. Tang, The University of Texas M. D. Anderson Cancer Center, Smithville, TX; S. Amin, American Health Foundation, Valhalla, NY.
Correspondence to: Gerd P. Pfeifer, Ph.D., Department of Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010 (e-mail: gpfeifer{at}coh.org).
Background: Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in combustion products of organic matter, including cigarette smoke. Metabolically activated diol epoxides of these compounds, including benzo[a]pyrene diol epoxide (B[a]PDE), have been suggested as causative agents in the development of lung cancer. We previously mapped the distribution of B[a]PDE adducts within the p53 tumor suppressor gene (also known as TP53), which is mutated in 60% of human lung cancers, and found that B[a]PDE adducts preferentially form at lung cancer mutational hotspots (codons 154, 157, 158, 245, 248, and 273). Other PAHs may be important in lung cancer as well. Methods: Here we have mapped the distribution of adducts induced by diol epoxides of additional PAHs: chrysene (CDE), 5-methylchrysene (5-MCDE), 6-methylchrysene (6-MCDE), benzo[c]phenanthrene (B[c]PDE), and benzo[g]chrysene (B[g]CDE) within exons 5, 7, and 8 of the p53 gene in human bronchial epithelial cells. Results: CDE exposure produced only low levels of adducts. Exposure of cells to the other activated PAHs resulted in DNA damage patterns similar to those previously observed with B[a]PDE but with some distinct differences. 5-MCDE, 6-MCDE, B[g]CDE, and B[c]PDE efficiently induced adducts at guanines within codons 154, 156, 157, 158, and 159 of exon 5, codons 237, 245 and 248 of exon 7, and codon 273 of exon 8, but the relative levels of adducts at each site varied for each compound. B[g]CDE, B[c]PDE, and 5-MCDE induced damage at codon 158 more selectively than 6-MCDE or B[a]PDE. The sites most strongly involved in PAH adduct formation were also the sites of highest mutation frequency (codons 157, 158, 245, 248, and 273). Conclusion: The data suggest that PAHs contribute to the mutational spectrum in human lung cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Ding, B. Ning, W. Gong, W. Wen, K. Wu, J. Liang, G. He, S. Huang, W. Sun, T. Han, et al. Cyclin D1 Induction by Benzo[a]pyrene-7,8-diol-9,10-epoxide via the Phosphatidylinositol 3-Kinase/Akt/MAPK- and p70s6k-dependent Pathway Promotes Cell Transformation and Tumorigenesis J. Biol. Chem., November 27, 2009; 284(48): 33311 - 33319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Anna, R. Holmila, K. Kovacs, E. Gyorffy, Z. Gyori, J. Segesdi, J. Minarovits, I. Soltesz, S. Kostic, A. Csekeo, et al. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary Mutagenesis, November 1, 2009; 24(6): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Rudin, E. Avila-Tang, C. C. Harris, J. G. Herman, F. R. Hirsch, W. Pao, A. G. Schwartz, K. H. Vahakangas, and J. M. Samet Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications Clin. Cancer Res., September 15, 2009; 15(18): 5646 - 5661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vaissiere, R. J. Hung, D. Zaridze, A. Moukeria, C. Cuenin, V. Fasolo, G. Ferro, A. Paliwal, P. Hainaut, P. Brennan, et al. Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors Cancer Res., January 1, 2009; 69(1): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Besaratinia, S.-i. Kim, and G. P. Pfeifer Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells FASEB J, July 1, 2008; 22(7): 2379 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Munnia, F. Saletta, A. Allione, S. Piro, M. Confortini, G. Matullo, and M. Peluso 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies Mutagenesis, November 1, 2007; 22(6): 381 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Y. Ho, M. Parent, and M. S. Satoh Induction of Base Damages Representing a High Risk Site for Double-strand DNA Break Formation in Genomic DNA by Exposure of Cells to DNA Damaging Agents J. Biol. Chem., July 27, 2007; 282(30): 21913 - 21923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Heist, W. Zhou, L. R. Chirieac, T. Cogan-Drew, G. Liu, L. Su, D. Neuberg, T. J. Lynch, J. C. Wain, and D. C. Christiani MDM2 Polymorphism, Survival, and Histology in Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., June 1, 2007; 25(16): 2243 - 2247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht Smoking and lung cancer--a new role for an old toxicant? PNAS, October 24, 2006; 103(43): 15725 - 15726. [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, Y. Hu, and M.-s. Tang From the Cover: Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair PNAS, October 17, 2006; 103(42): 15404 - 15409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hagiwara, L. E. Mechanic, G. E. Trivers, H. L. Cawley, M. Taga, E. D. Bowman, K. Kumamoto, P. He, M. Bernard, S. Doja, et al. Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers Cancer Res., August 15, 2006; 66(16): 8309 - 8317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia and G. P. Pfeifer Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis Carcinogenesis, August 1, 2006; 27(8): 1526 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ding, J. Li, J. Chen, H. Chen, W. Ouyang, R. Zhang, C. Xue, D. Zhang, S. Amin, D. Desai, et al. Effects of Polycyclic Aromatic Hydrocarbons (PAHs) on Vascular Endothelial Growth Factor Induction through Phosphatidylinositol 3-Kinase/AP-1-dependent, HIF-1{alpha}-independent Pathway J. Biol. Chem., April 7, 2006; 281(14): 9093 - 9100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arakawa, F. Wu, M. Costa, W. Rom, and M.-s. Tang Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites Carcinogenesis, March 1, 2006; 27(3): 639 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Singh and P. B. Farmer Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection Carcinogenesis, February 1, 2006; 27(2): 178 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mouron, C. A. Grillo, F. N. Dulout, and C. D. Golijow Genotoxic Effects of Benzo[a]pyrene and Dibenzo[a,l]pyrene in a Human Lung Cell Line International Journal of Toxicology, January 1, 2006; 25(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Jackson, K. P. Olive, D. A. Tuveson, R. Bronson, D. Crowley, M. Brown, and T. Jacks The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung Cancer Cancer Res., November 15, 2005; 65(22): 10280 - 10288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-Y. Seo, A. Nagalingam, M. Tiffany, and E. L. Loechler Mutagenesis studies with four stereoisomeric N2-dG benzo[a]pyrene adducts in the identical 5'-CGC sequence used in NMR studies: G->T mutations dominate in each case Mutagenesis, November 1, 2005; 20(6): 441 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Gritz, C. Dresler, and L. Sarna Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peluso, A. Munnia, G. Hoek, M. Krzyzanowski, F. Veglia, L. Airoldi, H. Autrup, A. Dunning, S. Garte, P. Hainaut, et al. DNA Adducts and Lung Cancer Risk: A Prospective Study Cancer Res., September 1, 2005; 65(17): 8042 - 8048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Le Calvez, A. Mukeria, J. D. Hunt, O. Kelm, R. J. Hung, P. Taniere, P. Brennan, P. Boffetta, D. G. Zaridze, and P. Hainaut TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers Cancer Res., June 15, 2005; 65(12): 5076 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, M. P. McDermott, and S. A. Ahrendt The p53 Codon 72 Proline Allele Is Associated with p53 Gene Mutations in Non-Small Cell Lung Cancer Clin. Cancer Res., April 1, 2005; 11(7): 2502 - 2509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Lan, J. L. Mumford, M. Shen, D. M. DeMarini, M. R. Bonner, X. He, M. Yeager, R. Welch, S. Chanock, L. Tian, et al. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions Carcinogenesis, November 1, 2004; 25(11): 2177 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, A. Besaratinia, Z. Feng, M.-s. Tang, S. Amin, A. Luch, and G. P. Pfeifer DNA Damage, Repair, and Mutation Induction by (+)-Syn and (-)-Anti-Dibenzo[a,l]Pyrene-11,12-Diol-13,14-Epoxides in Mouse Cells Cancer Res., October 15, 2004; 64(20): 7321 - 7328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ramesh, S. A. Walker, D. B. Hood, M. D. Guillen, K. Schneider, and E. H. Weyand Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons International Journal of Toxicology, September 1, 2004; 23(5): 301 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, H. Chen, M.-S. Tang, X. Shi, S. Amin, D. Desai, M. Costa, and C. Huang PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells J. Cell Biol., April 12, 2004; 165(1): 77 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Valadez and F. P. Guengerich S-(2-Chloroethyl)glutathione-generated p53 Mutation Spectra Are Influenced by Differential Repair Rates More than Sites of Initial DNA Damage J. Biol. Chem., April 2, 2004; 279(14): 13435 - 13446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, Z. Feng, and M.-s. Tang Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis Carcinogenesis, March 1, 2004; 25(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia and G. P. Pfeifer Enhancement of the Mutagenicity of Benzo(a)pyrene Diol Epoxide by a Nonmutagenic Dose of Ultraviolet A Radiation Cancer Res., December 15, 2003; 63(24): 8708 - 8716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Spivack, G. J. Hurteau, M. J. Fasco, and L. S. Kaminsky Phase I and II Carcinogen Metabolism Gene Expression in Human Lung Tissue and Tumors Clin. Cancer Res., December 1, 2003; 9(16): 6002 - 6011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Ahrendt, Y. Hu, M. Buta, M. P. McDermott, N. Benoit, S. C. Yang, L. Wu, and D. Sidransky p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study J Natl Cancer Inst, July 2, 2003; 95(13): 961 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Breton, F. Sichel, A. Abbas, J. Marnay, D. Arsene, and M. Lechevrel Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France) Mutagenesis, May 1, 2003; 18(3): 299 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, M. Costa, and M.-S. Tang Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells Carcinogenesis, April 1, 2003; 24(4): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, C.-S. Lee, and G. P. Pfeifer Simulated sunlight and benzo[a]pyrene diol epoxide induced mutagenesis in the human p53 gene evaluated by the yeast functional assay: lack of correspondence to tumor mutation spectra Carcinogenesis, January 1, 2003; 24(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Alexandrov, I. Cascorbi, M. Rojas, G. Bouvier, E. Kriek, and H. Bartsch CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis, December 1, 2002; 23(12): 1969 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, Z. Feng, J. Eveleigh, G. Iyer, J. Pan, S. Amin, F.-L. Chung, and M.-s. Tang The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma Carcinogenesis, November 1, 2002; 23(11): 1781 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, J. X. Chen, A. Pao, H. Li, W. Rom, M.-C. Hung, and M.-s. Tang Preferential DNA Damage and Poor Repair Determine ras Gene Mutational Hotspot in Human Cancer J Natl Cancer Inst, October 16, 2002; 94(20): 1527 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J Epidemiol Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, F. A. Beland, and M.-s. Tang 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene Carcinogenesis, October 1, 2002; 23(10): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu and N. Gooderham Neoplastic Transformation of Human Lung Fibroblast MRC-5 SV2 Cells Induced by Benzo[a]pyrene and Confluence Culture Cancer Res., August 15, 2002; 62(16): 4605 - 4609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia, S. E. Bates, and G. P. Pfeifer Mutational Signature of the Proximate Bladder Carcinogen N-Hydroxy-4-acetylaminobiphenyl: Inconsistency with the p53 Mutational Spectrum in Bladder Cancer Cancer Res., August 1, 2002; 62(15): 4331 - 4338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Cooper Smoking, lung cancers and their TP53 mutations Mutagenesis, July 1, 2002; 17(4): 279 - 280. [Full Text] [PDF]
|
|
|
|
|
|
A. Haugen Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, February 1, 2002; 23(2): 227 - 229. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Belinsky, S. S. Snow, K. J. Nikula, G. L. Finch, C. S. Tellez, and W. A. Palmisano Aberrant CpG island methylation of the p16INK4a and estrogen receptor genes in rat lung tumors induced by particulate carcinogens Carcinogenesis, February 1, 2002; 23(2): 335 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hainaut, M. Olivier, and G. P. Pfeifer TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database Mutagenesis, November 1, 2001; 16(6): 551 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wolf, Y. C. Hu, K. Doffek, D. Sidransky, and S. A. Ahrendt O6-Methylguanine-DNA Methyltransferase Promoter Hypermethylation Shifts the p53 Mutational Spectrum in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(22): 8113 - 8117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers Cancer Res., October 1, 2001; 61(19): 7110 - 7117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-L. Hsieh, P.-F. Wang, I.-H. Chen, C.-T. Liao, H.-M. Wang, M.-C. Chen, J. T.-C. Chang, and A.-J. Cheng Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese Carcinogenesis, September 1, 2001; 22(9): 1497 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Hussain, P. Amstad, K. Raja, M. Sawyer, L. Hofseth, P. G. Shields, A. Hewer, D. H. Phillips, D. Ryberg, A. Haugen, et al. Mutability of p53 Hotspot Codons to Benzo(a)pyrene Diol Epoxide (BPDE) and the Frequency of p53 Mutations in Nontumorous Human Lung Cancer Res., September 1, 2001; 61(17): 6350 - 6355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. DeMarini, S. Landi, D. Tian, N. M. Hanley, X. Li, F. Hu, B. C. Roop, M. J. Mass, P. Keohavong, W. Gao, et al. Lung Tumor KRAS and TP53 Mutations in Nonsmokers Reflect Exposure to PAH-Rich Coal Combustion Emissions Cancer Res., September 1, 2001; 61(18): 6679 - 6681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F Costello and C. Plass Methylation matters J. Med. Genet., May 1, 2001; 38(5): 285 - 303. [Abstract] [Full Text]
|
|
|
|
|
|
P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Arlt, H. H. Schmeiser, and G. P. Pfeifer Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR Carcinogenesis, January 1, 2001; 22(1): 133 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Davis, D. A. Weidner, A. Holian, and D. J. McConkey Nitric Oxide-Dependent Activation of P53 Suppresses Bleomycin-Induced Apoptosis in the Lung J. Exp. Med., September 18, 2000; 192(6): 857 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht Metabolically Activated Carcinogens and Mutations in the p53 Tumor Suppressor Gene in Lung Cancer J Natl Cancer Inst, May 17, 2000; 92(10): 782 - 783. [Full Text] [PDF]
|
|